High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Shopify just posted its biggest single-day earnings pop in recent memory, and the rally may not be finished. Here is where the stock could land before December and what threatens to knock it off course.
The Wendy’s Company will release its second-quarter earnings report before the opening bell on Friday, Aug. 7. Analysts expect the company to report quarterly earnings of 16 cents per share, down from 29 cents per share in the year-ago period....
According to the average brokerage recommendation (ABR), one should invest in Unity Software (U). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
The headline numbers for Take-Two (TTWO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Although the revenue and EPS for Datadog (DDOG) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The average brokerage recommendation (ABR) for Wells Fargo (WFC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Although the revenue and EPS for Wendy's (WEN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The average brokerage recommendation (ABR) for Analog Devices (ADI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
The average brokerage recommendation (ABR) for Sterling Infrastructure (STRL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
According to the average brokerage recommendation (ABR), one should invest in Citigroup (C). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
The firm’s valuation gives CleanSpark credit for its contracted Sandersville campus and prospective Texas leases, while treating additional sites as largely unpriced.
Keep this in mind about Sandisk.
Take-Two topped Wall Street's revenue and earnings estimates in the fiscal first quarter.
Energy stocks were declining premarket Friday, with the State Street Energy Select Sector SPDR ETF (
Needham cited stronger tenant demand through MARA’s Starwood partnership, but withheld a price target pending more detail on the joint venture’s economics.
The video game publisher reported first-quarter net bookings of $1.39 billion, slightly above its own guidance range
Alphabet's recurring revenue businesses will boost its stock over the next decade.
SpaceX is poised to close out a pivotal week in the green, with the stock fighting higher over the past five sessions after reporting its first earnings report as a public company, and the largest share unlock in its brief trading history.
There's been a rush for bullish stock bets this week. More than 10 million call options tied to the State Street SPDR S&P 500 ETF Trust traded in a single session earlier this week, the highest one-day sum on record, according to Cboe Global Markets data.
Evaluate the expected performance of Cisco (CSCO) for the quarter ended July 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Besides Wall Street's top-and-bottom-line estimates for Pan American Silver (PAAS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Besides Wall Street's top-and-bottom-line estimates for Trimble (TRMB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Tutor Perini (TPC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Netflix stock looks attractive to value investors, especially to out-of-the-money (OTM) short-put investors. For example, a 2.0% yield for one month is available on a put option with a 5% lower strike price.
The company plans to require large commercial users of Qwen3.8-Max to share a portion of revenue, following a similar move by Moonshot AI
Atlassian (NasdaqGS:TEAM) appoints Ken Exner as Chief Product Officer for Enterprise and Emerging products. Exner brings roughly three decades of product leadership experience from Amazon Web Services and Elastic. The role centers on expanding Atlassian's enterprise solutions and security focused offerings. The move comes as demand grows for cloud tools with strong governance, compliance, and security features. For readers watching Atlassian's leadership moves and looking for more companies...
NANO Nuclear Energy (NNE) stock is in focus after the company was selected by AFWERX for a SBIR Phase I contract centered on its KRONOS MMR Energy System for Air Force applications. See our latest analysis for NANO Nuclear Energy. The AFWERX contract and upcoming third quarter 2026 business update come after a mixed period for NANO Nuclear Energy, with the share price down 36.2% year to date but up over the past week, while the 1 year total shareholder return has declined 52.3%. If you want...
Moderna (NasdaqGS:MRNA) has initiated a Phase 1 clinical trial in Canada for its investigational mRNA vaccine targeting Bundibugyo ebolavirus. The program addresses a strain of Ebola that currently has no approved vaccine and is positioned as part of Moderna's broader infectious disease portfolio. The trial involves collaboration with CEPI and Canadian public health authorities, with a stated focus on access for low and middle income countries. This kind of targeted vaccine work highlights...
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
